Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥791,908 million (YoY +9.0%) |
| Operating profit | ¥-4,846 million |
| Ordinary income | ¥-4,976 million |
| Profit attributable to owners of the parent | ¥-5,964 million |
| Net income per share | (¥16.59) |
| Equity ratio | End of the current fiscal period 16.6 / End of previous period 16.8 |
| Total assets | ¥4,651,811 million |
| Net assets | ¥771,586 million |
| Cash flows from operating activities | ¥-13,485 million |
| Cash flows from investing activities | ¥-145,478 million |
| Cash flows from financing activities | ¥76,254 million |
| Cash and cash equivalents at end of period | ¥336,267 million |
| Full-year earnings forecast | Net Sales ¥1,630,000 million (YoY +13.0%) / Operating profit ¥43,000 million (YoY -52.3%) / Ordinary income ¥38,000 million (YoY -52.6%) / Net income ¥35,000 million (YoY -48.9%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥1,630,000 million / Operating profit Not disclosed → ¥43,000 million / Ordinary income Not disclosed → ¥38,000 million / Net income Not disclosed → ¥35,000 million |
| Annual Dividend Forecast | ¥27 → ¥40(+48.1%) |
| Depreciation and amortization | ¥65,663 million |
| Impairment loss | ¥551 million |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | No material changes (the number and names of companies newly included in or excluded from consolidation are Not disclosed) |
| Material subsequent events | The company resolved to tender its 6,300,000 shares in CHUDENKO CORPORATION, an equity-method affiliate, in CHUDENKO CORPORATION's tender offer for its own shares. The planned total sale proceeds are ¥29,068 million, and if all the shares are sold, the company expects to record an approximately ¥5 billion gain on the sale of shares in an affiliate as extraordinary income in the current consolidated fiscal year. CHUDENKO CORPORATION will remain an equity-method affiliate after the tender offer, and the company intends to continue holding shares. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and securities analysts |
| Issued Shares at Period-End | 387,154,692 |
| Treasury Shares at Period-End | 27,524,374 |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The text does not state the reasons for the deterioration in interim results or the revision to the full-year forecasts. It also explains, as a subsequent event, that the company will tender part of its shareholdings in a tender offer to optimize its capital relationship with CHUDENKO CORPORATION and improve capital efficiency.